Trust, Digital Innovation, Metaverse and Pharma Launches: What is the Connection? with Brendan Gallager of Publicis Health
In this episode of Pharma Launch Secrets, Bozidar is joined by Brendan Gallagher, Chief Connected Health Officer at Publicis Health. They discuss the impact of the pandemic on pharma and biotech companies and how COVID-19 is driving them to evolve their product launch strategy.
Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide
In this episode, Bozidar is joined by Brendan Gallagher, Chief Connected Health Officer at Publicis Health.
- What impact did COVID-19 have on driving pharma and biotech companies to evolve their product launch strategy?
- How can pharma companies ensure their content remains relevant without jeopardizing brand integrity?
- What are the potential benefits of utilizing new technologies like the metaverse and web3 in the pharma industry?
- How can pharma companies meet the increasing demand for a more robust end-to-end launch collaboration?
If you want to learn more about current trends in the pharma industry, product launching, and the prospect of digital launching in the pharma industry, tune in to this episode of Pharma Launch Secrets, a Podcast by Evermed.
And connect with the host and guest here:
About The Show:
“Pharma Launch Secrets” is a podcast by Evermed and hosted by Bozidar Jovanovic, where we host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.